US Patent

US10646495 — Testosterone ester triglyceride formulations

Formulation · Assigned to Antares Pharma Inc · Expires 2038-08-30 · 12y remaining

Vulnerability score 42/100 Strong — defensible against typical IPR challenges

What this patent protects

Testosterone ester triglyceride formulations, optionally further including adducts. Methods of in-situ control of the manufacture or formation of such adducts are also described.

USPTO Abstract

Testosterone ester triglyceride formulations, optionally further including adducts. Methods of in-situ control of the manufacture or formation of such adducts are also described.

Drugs covered by this patent

Patent Metadata

Patent number
US10646495
Jurisdiction
US
Classification
Formulation
Expires
2038-08-30
Drug substance claim
No
Drug product claim
Yes
Assignee
Antares Pharma Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.